Common Contracts
3 similar Option for a License Agreement contracts by Macrogenics Inc
EX-10.20 8 d575431dex1020.htm EX-10.20 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. EXECUTION COPY 121752/BR/BCN OPTION FOR A LICENSE AGREEMENT BY AND BETWEEN...Option for a License Agreement • May 5th, 2020
This Option for a License Agreement (this “Agreement”) is entered into and made effective as of the 19th day of September, 2012 (the “Effective Date”), by and between MacroGenics, Inc. a corporation organized and existing under the laws of the State of Delaware and having a principal office located at 9640 Medical Center Drive Rockville, MD 20850, USA (“MacroGenics”), and Les Laboratoires Servier, a company organized and existing under the laws of France, having a principal office located at 50 rue Carnot 92284 Suresnes (“LLS”) and Institut de Recherches Servier, a company organized and existing under the laws of France, having a principal office located at 3 rue de la République - 92150 Suresnes - France (“IdRS”) and LLS and IdRS hereinafter collectively referred to as “Servier”). MacroGenics and Servier are each referred to herein by name or as a “Party” or, collectively, as “Parties.”
OPTION FOR A LICENSE AGREEMENT BY AND BETWEEN MACROGENICS, INC. AND LES LABORATOIRES SERVIER AND INSTITUT DE RECHERCHES SERVIEROption for a License Agreement • October 4th, 2013 • Macrogenics Inc • Pharmaceutical preparations
In no event shall the total of the amounts paid under this Section 9.3.2 for the *** Licensed Program and gpA33 Licensed Program exceed ***, or exceed *** for the CD 123 Licensed Program, and exceed *** in the aggregate for all of the Licensed Programs.
OPTION FOR A LICENSE AGREEMENT BY AND BETWEEN MACROGENICS, INC. AND LES LABORATOIRES SERVIER AND INSTITUT DE RECHERCHES SERVIEROption for a License Agreement • September 4th, 2013 • Macrogenics Inc • Pharmaceutical preparations
In no event shall the total of the amounts paid under this Section 9.3.2 for the *** Licensed Program and gpA33 Licensed Program exceed ***, or exceed *** for the CD 123 Licensed Program, and exceed *** in the aggregate for all of the Licensed Programs.
